WHO ICTRP trial
Development and Application of a Predictive Model for Clinical Cure in Chronic…
ChiCTR2500113938 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500113938 |
|---|---|
| Public title | Development and Application of a Predictive Model for Clinical Cure in Chronic Hepatitis B |
| Scientific title | Construction and Application of a Model for Early Prediction of Clinical Cure in Inactive HBsAg Carriers Treated with Peginterferon Alpha Based on Immunomics Data and Multimodal Imaging Features |
| Primary sponsor | The Second Affiliated Hospital of Xi’an Jiaotong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Chronic hepatitis B |
| Interventions | Peg-IFN-a group:None;Patients received no treatment group:None |
| Registration date | Dec 4, 2025 |
| Target size | Peg-IFN-a group:1000;Patients received no treatment group:1000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: